BIOMAT Database Logo BIOMAT Database Logo

[Urinary lysozyme, beta-2-microglobulin, and alpha-glucosidase during cisplatin therapy]. 1983

M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum

Related Publications

M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
[Functional recovery phase of acute renal insufficiency. Behavior and significance of urinary excretion of alpha-glucosidase, gamma-glutamyltransferase, lysozyme and beta 2 microglobulin].
January 1980, Minerva nefrologica,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Proteinuria after human renal transplantation. I. Urinary excretion of alpha-2-microglobulin (retinol-binding protein), beta-2-microglobulin, lysozyme and albumin.
January 1974, Scandinavian journal of urology and nephrology,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
[Urinary alpha 1-microglobulin and beta 2-microglobulin in diabetes mellitus].
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
[Urinary beta 2-microglobulin].
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
[Alpha 1-microglobulin, beta 2-microglobulin].
August 2002, Nihon rinsho. Japanese journal of clinical medicine,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Urinary excretion of beta-2-microglobulin and albumin during antibiotic therapy in urinary tract infections.
January 1981, Contributions to nephrology,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
July 1995, Clinical nephrology,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity.
January 1981, Cancer treatment reports,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.
March 1986, Journal of the neurological sciences,
M Airoldi, and F Pecchio, and F Albanese, and V Mastromatteo, and A Gariboldi, and G Di Costanzo, and M Fazio
Relationship between urine beta-2-microglobulin and platinum levels during cisplatin treatment.
January 1988, Clinical biochemistry,
Copied contents to your clipboard!